261763-23-9 Usage
General Description
4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL BROMIDE is a chemical compound with the molecular formula C8H6BrClF3. It is a benzyl bromide derivative with a chloro group at the 4-position and a trifluoromethyl group at the 3-position of the benzene ring. This chemical is commonly used as an intermediate in the synthesis of pharmaceuticals and agrochemicals. It is also used in organic synthesis as a reagent for introducing the benzyl bromide functionality into various compounds. Additionally, it can be used as a building block for the production of other specialty chemicals. 4-CHLORO-3-(TRIFLUOROMETHYL)BENZYL BROMIDE should be handled and used with care due to its reactivity and potential health hazards.
Check Digit Verification of cas no
The CAS Registry Mumber 261763-23-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,1,7,6 and 3 respectively; the second part has 2 digits, 2 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 261763-23:
(8*2)+(7*6)+(6*1)+(5*7)+(4*6)+(3*3)+(2*2)+(1*3)=139
139 % 10 = 9
So 261763-23-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H5BrClF3/c9-4-5-1-2-7(10)6(3-5)8(11,12)13/h1-3H,4H2
261763-23-9Relevant articles and documents
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2 H-benzo[ b][1,4]oxazin-6-yl Moiety
Ikeda, Shuhei,Sugiyama, Hideyuki,Tokuhara, Hidekazu,Murakami, Masataka,Nakamura, Minoru,Oguro, Yuya,Aida, Jumpei,Morishita, Nao,Sogabe, Satoshi,Dougan, Douglas R.,Gay, Sean C.,Qin, Ling,Arimura, Naoto,Takahashi, Yasuko,Sasaki, Masako,Kamada, Yusuke,Aoyama, Kazunobu,Kimoto, Kouya,Kamata, Makoto
, p. 11014 - 11044 (2021/08/24)
The therapeutic potential of monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases has attracted attention worldwide. However, the availability of reversible-type inhibitor is still limited to clarify the pharmacological eff
